Ernexa Therapeutics Inc.

ERNA·NASDAQ·$11.43Share Price as of 11/2·$4MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/06/26 10-QQ1 ended 03/31/2605/11/26 10-KFY 202503/13/26 10-QQ3 ended 09/30/2511/07/25 10-QQ2 ended 06/30/2508/13/25

Disclosures

8-KCurrent report10/15/26 8-KCurrent report09/16/26 8-KCurrent report09/16/26 8-KCurrent report07/02/26 8-KCurrent report07/02/26

Prospectuses and Registrations

S-3/AShelf registration (amended)03/24/26 S-3Shelf registration03/16/26 424B5Prospectus supplement02/10/26 S-1/ARegistration statement (amended)02/05/26 S-1/ARegistration statement (amended)02/04/26

Proxies

DEF 14ADefinitive proxy05/11/26 DEFA14AAdditional proxy materials05/11/26 DEF 14CDefinitive information statement04/13/26 PRE 14CPRE 14C04/01/26 DEF 14ADefinitive proxy04/14/25

Ownership

Form 3Initial insider ownership09/22/26 Form 4Insider transaction09/01/26 Form 4Insider transaction09/01/26 Form 4Insider transaction09/01/26 Form 4Insider transaction09/01/26

Other

ARSAnnual report to shareholders05/11/26 EFFECTRequest for effectiveness03/30/26 CORRESPCorrespondence with the SEC03/26/26 UPLOADLetter from the SEC03/20/26 8-A12B8-A12B02/05/26